CCS researchers have written an article which looks at the clinical presentation of risk factors of hepatitis C virus among HIV-infected patients in Bissau, Guinea-Bissau.
According to the study, approximately 34 million people are infected with HIV worldwide, of whom one to two million have an HIV-2 infection, an epidemic mainly confined to West Africa. The West African country Guinea-Bissau is currently experiencing a rise in HIV-1 prevalence and at the same time holds the world's highest prevalence of HIV-2.
It notes that an estimated 170 million people are chronically infected with hepatitis C virus and more than three million are infected annually.Since reliable hepatitis C virus tests are not available for widespread screening in low-resource settings, physicians must often rely on clinical intuition. Unfortunately, data on symptoms and objective signs of chronic hepatitis C virus infection in Sub-Saharan Africa are scarce.
The study found that the prevalence of hepatitis C virus infection was comparable to that in other West African countries, and as reported by several other studies, the prevalence was higher among individuals aged ≥50 years. The transmission routes of hepatitis C virus in Guinea-Bissau remain unclear, and it is recommended that future studies investigate whether hepatitis C virus prevalence is declining. Among the HIV-infected patients in Guinea-Bissau, hepatitis C virus infection is a silent disease making screening tests necessary to diagnose co-infection.
Click here to read the full study.
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.